PT2125620E - Produção de tório 228 a partir de um sal de tório natural - Google Patents

Produção de tório 228 a partir de um sal de tório natural

Info

Publication number
PT2125620E
PT2125620E PT87179214T PT08717921T PT2125620E PT 2125620 E PT2125620 E PT 2125620E PT 87179214 T PT87179214 T PT 87179214T PT 08717921 T PT08717921 T PT 08717921T PT 2125620 E PT2125620 E PT 2125620E
Authority
PT
Portugal
Prior art keywords
thorium
salt
radium
coprecipitate
natural
Prior art date
Application number
PT87179214T
Other languages
English (en)
Inventor
Gilbert Andreoletti
Michel Belieres
Pascal Nardoux
Jean Paul Moulin
Anne Montaletang
Patrick Bourdet
Original Assignee
Areva Nc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Areva Nc filed Critical Areva Nc
Publication of PT2125620E publication Critical patent/PT2125620E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F15/00—Compounds of thorium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A61K51/1096—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/88—Isotope composition differing from the natural occurrence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Geology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
PT87179214T 2007-03-19 2008-03-18 Produção de tório 228 a partir de um sal de tório natural PT2125620E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0753909A FR2913970B1 (fr) 2007-03-19 2007-03-19 Production de thorium 228 a partir d'un sel de thorium naturel
US91139007P 2007-04-12 2007-04-12

Publications (1)

Publication Number Publication Date
PT2125620E true PT2125620E (pt) 2013-10-15

Family

ID=38727521

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87179214T PT2125620E (pt) 2007-03-19 2008-03-18 Produção de tório 228 a partir de um sal de tório natural

Country Status (17)

Country Link
US (1) US8221520B2 (pt)
EP (1) EP2125620B1 (pt)
JP (1) JP5468910B2 (pt)
KR (1) KR101477758B1 (pt)
CN (1) CN101646625B (pt)
AU (1) AU2008228296B2 (pt)
CA (1) CA2681180C (pt)
DK (1) DK2125620T3 (pt)
ES (1) ES2435795T3 (pt)
FR (1) FR2913970B1 (pt)
HR (1) HRP20131061T1 (pt)
PL (1) PL2125620T3 (pt)
PT (1) PT2125620E (pt)
RU (1) RU2461518C2 (pt)
SI (1) SI2125620T1 (pt)
WO (1) WO2008113792A2 (pt)
ZA (1) ZA200906155B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012032043A1 (en) 2010-09-07 2012-03-15 Areva Med Llc 212 pb imaging
RU2513206C1 (ru) * 2012-10-30 2014-04-20 Леонид Асхатович Мазитов Способ разделения тория-228 и радия-224
US10636536B1 (en) 2017-02-13 2020-04-28 Radtran Llc Systems and methods for preparing tailored radioactive isotope solutions
KR101921226B1 (ko) * 2017-02-14 2019-02-13 (주)이젝스 전원 공급 장치 및 그 방법
FR3088769B1 (fr) * 2018-11-15 2020-12-25 Orano Med Procede de preparation d'au moins un generateur a haute teneur en radium-228
WO2023023731A1 (en) * 2021-08-23 2023-03-02 AdvanCell Isotopes Pty Limited Materials and processes for generating radioisotope

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265862A (en) * 1979-01-25 1981-05-05 Eastman Kodak Company Process for purifying rare-earth compositions using fractional sulfate precipitation
CA1145487A (en) * 1980-08-22 1983-04-26 Donald R. Weir Removal of radium from aqueous sulphate solutions
JPS6065721A (ja) * 1983-09-20 1985-04-15 Mitsubishi Chem Ind Ltd 塩化希土の精製法
US4649029A (en) * 1984-04-13 1987-03-10 Inderjit Nirdosh Processes for extraction of uranium and radium from uranium-containing ores using ferric nitrate
FR2750414B1 (fr) * 1996-07-01 1998-10-16 Rhone Poulenc Chimie Procede de traitement d'un melange comprenant un compose de terre rare et des elements radioactifs du type radium, thorium et uranium
JP2001040598A (ja) * 1999-07-28 2001-02-13 Moruza Kk 天然放射性希有元素鉱物微粒子を担持した紙及びその製造方法
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
DE10040771A1 (de) * 2000-08-21 2002-03-14 Altmann Therapie Gmbh & Co Kg Neue, 224Ra enthaltende, radiotherapeutisch wirksame Formulierungen und Verfahren zu ihrer Herstellung
US6951634B2 (en) * 2002-09-18 2005-10-04 Battelle Energy Alliance, Llc Process for recovery of daughter isotopes from a source material
RU2246550C1 (ru) * 2003-06-24 2005-02-20 ООО Научно-производственная экологическая фирма "ЭКО-технология" Способ переработки торийсодержащих радиоактивных отходов
FR2904888B1 (fr) * 2006-08-11 2008-12-19 Cezus Cie Europ Du Zirconium S Methode de stabilisation du radium dans les effluents radiferes.
US20100018347A1 (en) * 2006-10-05 2010-01-28 Holden Charles S Separation of radium and rare earth elements from monazite

Also Published As

Publication number Publication date
CN101646625A (zh) 2010-02-10
US20100104467A1 (en) 2010-04-29
PL2125620T3 (pl) 2013-12-31
WO2008113792A3 (en) 2008-11-13
KR20100015649A (ko) 2010-02-12
EP2125620A2 (en) 2009-12-02
FR2913970B1 (fr) 2009-06-12
CA2681180A1 (en) 2008-09-25
US8221520B2 (en) 2012-07-17
FR2913970A1 (fr) 2008-09-26
EP2125620B1 (en) 2013-08-07
CN101646625B (zh) 2012-11-28
JP2010521403A (ja) 2010-06-24
HRP20131061T1 (hr) 2013-12-06
ZA200906155B (en) 2010-05-26
AU2008228296B2 (en) 2013-05-02
RU2009138249A (ru) 2011-04-27
JP5468910B2 (ja) 2014-04-09
ES2435795T3 (es) 2013-12-23
CA2681180C (en) 2014-07-08
RU2461518C2 (ru) 2012-09-20
AU2008228296A1 (en) 2008-09-25
SI2125620T1 (sl) 2013-10-30
WO2008113792A2 (en) 2008-09-25
DK2125620T3 (da) 2013-11-04
KR101477758B1 (ko) 2015-01-02

Similar Documents

Publication Publication Date Title
PT2125620E (pt) Produção de tório 228 a partir de um sal de tório natural
HN2011003187A (es) Metodo mejorado para sintetizar pirfenidona
AR073185A1 (es) Proceso para la produccion de hidroxido de magnesio de alta pureza
CL2016000484A1 (es) Proceso para recuperar de cobre y/o metal precioso mediante lixiviación con un lixiviante alcalino y un aminoácido o derivado del mismo; solución de lixiviación alcalina que comprende aminoácido o un derivado del mismo y que tiene un ph de al menos 9.
TN2015000372A1 (en) A method for concentrating rare-earth metals in phosphogypsum
UA113693C2 (xx) Титановмісна сполука, спосіб одержання титановмісної сполуки і застосування титановмісної сполуки в культивації рослин
MX2019001031A (es) Proceso para producir sulfato de sodio a partir de fosfoyeso.
BR112014031919A2 (pt) processo para produção de ácido acético
SA112330848B1 (ar) تحضير حمض ميثاكريليك
DE50112630D1 (de) Neue, 224 ra enthaltende, radiotherapeutisch wirksame formulierungen und verfahren zu ihrer herstellung
WO2013023254A8 (en) Method for the recovery of magnesium sulphate and production of magnesium oxide
AR107298A1 (es) Método de purificación
CO6380006A1 (es) Proceso para producción de magnetita sintética de alta pureza por oxidación a partir de residuos metálicos y aparato para producirla
IN2012DN04900A (pt)
TW200610575A (en) A recovery method for thallium-203 isotope from the residual liquid of thallium-201 radioactive isotope
RU2012133403A (ru) Способ получения микрокапсул лекарственных препаратов группы цефалоспоринов в конжаковой камеди в бутиловом спирте
AR086056A1 (es) Remocion de agua de una corriente de acido acetico en la produccion de alcoholes
JP6947008B2 (ja) ジルコニウムの標識方法
US11189388B2 (en) Methods for purifying molybdenum-99
ATE525368T1 (de) Herstellungsverfahren von stiripentolpartikeln, die eine definierte granulometrie haben
CN102370717A (zh) 治疗结膜炎的药
TH150183A (th) การเตรียมเมทาคริลิกแอซิด
CN103030587A (zh) 3-甲胺基哌啶的合成工艺
MX2012000670A (es) Proceso para elaboracion de reactivo vacunal de eritrocitos parasitados con babesia bovis o babesia bigemina.
RU2010136209A (ru) Способ получения радиофармацевтической композиции